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and regional variation in cartilage water content. We hypothesize that
loss of the normal spatial distribution of cartilage MRI T2 values, as
quantiﬁed by texture features, will identify distinctive signatures of OA
prior to symptomatic or radiographic evidence of OA. This change in T2
signal homogeneity could be used to predict symptomatic disease
progression.
Methods: Patients were selected from the Osteoarthritis Initiative (OAI)
databasebasedon the change in totalWOMACscore frombaseline to three
year follow-up (79 non-OA progression and 103 OA progression patients).
The incidence cohort was used to identify a rapid progression population
of OA deﬁned as asymptomaticwith no radiographic changes at the initial
time point (WOMAC<3; KL<2) that had a large increase inWOMAC score
(greater than 10) at the three year time point. For each patient, at baseline,
725 image texture features were measured from each knee T2 map. A
linear discriminant function and feature reduction method was then
trained to quantify a texturemetric, the T2 texture index of cartilage (TIC),
based on 20 image features, to identify early OA changes on MRI.
Results: Statistically signiﬁcant differences were seen in the T2 TIC
between the OA non-progression and progression populations at the
initial baseline measurement. This image biomarker differentiates
subjects that develop OA prior to clinically signiﬁcant OA symptoms or
radiographic ﬁndings with an accuracy of 80.3% 4.3%, a sensitivity of
83.4%  5.2% and a speciﬁcity of 77.4 4.8%. These image features used
to quantify signal homogeneity through a texture metric can be
considered “image biomarkers”. These features included run length, co-
occurrence matrix, entropy, and local energy measures. When the knee
is separated into the patella, medial, and lateral compartments, in more
than 80% of knees, the texture metric that identiﬁed a knee with early
signs of OA were primarily located in only one of these compartments.
These signal changes were observed in a dominant knee compartment
that correlated with the mechanical axis of the knee.
Conclusion: We demonstrate that the T2 TIC, derived from local vari-
ation in cartilage T2 values, is able to differentiate and predict indi-
viduals that will develop symptomatic knee OA from those that remain
asymptomatic. The observation that these image features are localized
to knee compartments associated with deviation of the mechanical axis
suggests this index reﬂects early structural cartilage change related to
biomechanical properties of the knee. The ability to differentiate
patients at risk for OA progression prior to symptomatic or radiographic
presentation based on qMRI signal changeswould be valuable in clinical
and epidemiological studies for disease-modifying OA drugs (DMOADs),
joint preservation surgical interventions, and the development of post-
traumatic arthritis in ACL and meniscal injuries.
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QUALITY OF LIFE AND RADIOGRAPHIC SEVERITY OF KNEE
OSTEOARTHRITIS PREDICT TOTAL KNEE ARTHROPLASTY: DATA
FROM THE OSTEOARTHRITIS INITIATIVE
M.C. Hochberg y,z, K. Favors y,z, J.D. Sorkin y,z. yUniv. of Maryland,
Baltimore, MD, USA; zVA Maryland Hlth. Care System, Baltimore, MD, USA
Purpose: Total knee arthroplasty (TKA) is a clinically important
outcome in persons with symptomatic osteoarthritis (OA) of the knee.
Few studies, however, have examined predictors of TKA in community-
based cohorts. We analyzed data from the Osteoarthritis Initiative (OAI)
to determine the most parsimonious group of baseline variables that
robustly predicted undergoing a TKA during 5 years of follow-up.
Methods: Data for this analysis were obtained from the OAI public
access database (http://www.oai.ucsf.edu). At each annual visit through
48 months, subjects completed an extensive battery of questionnaires,
weight was measured with a balance beam scale, and ﬁxed ﬂexion,
weight-bearing PA radiographs of both knees were obtained using
a standard protocol and the Synaﬂexer platform; the 60-month
follow-up visit only involved completion of questionnaires. Subjects
reported TKAs at the time of their annual follow-up visits; these were
conﬁrmed by the Coordinating Center after review of medical records
obtained by the Clinical Centers. We examined selected variables
measured at the baseline visit for their role as predictors of TKA using
knee-speciﬁc multiple variable logistic regression models. The best
models were selected for each knee based on Chi-square values and
area under the receiver operating characteristic curve (AUC).
Results: Data from 4674 subjects enrolled in the OAI who either had
symptomatic radiographic knee OA or were at risk for this conditionwere included in this analysis. At entry, subjects had a mean (SD) age of
61.32 (9.17) years and body mass index (BMI) of 28.74 (4.82) kg/m2;
2729 (58.4%) were women and 3677 (78.75%) were white. Baseline
knee-speciﬁcWOMAC pain (0-20 scale) and function (0-68 scale) scores
were 2.56 (3.26) and 8.26 (10.63) for the right knee and 2.39 (3.43) and
8.39 (11.44) for the left knee, respectively. Baseline KOOS pain and
symptoms scores (0-100 scale) were 83.56 (17.37) and 85.95 (14.60) for
the right knee and 84.80 (18.26) and 86.49 (15.87) for the left knee,
respectively; KOOS quality of life (QoL, 0-100 scale) was 66.10 (22.43).
Distribution of Kellgren-Lawrence (KL) grades of severity of radio-
graphic knee OA at baseline was similar for both knees: 37,18, 27,14 and
4 percent had Grade 0, 1, 2, 3, 4 changes, respectively. During 60months
of follow-up, there were 91 right and 102 left TKAs. In models con-
taining clinical variables and adjusted for age, gender, BMI and race, the
best models includedWOMAC pain and KOOS QoL (AUC¼ 0.80 and 0.82
for right and left knees, respectively). When KL grade was added to
these models, the AUC improved to 0.89 and 0.90 for the right and left
knees, respectively; race, BMI and WOMAC pain were no longer
signiﬁcantly associated with TKA outcome. The best parsimonious
model included age, gender, KOOS QoL score and KL grade with an
AUC ¼ 0.89 and 0.90 for the right and left knee, respectively. Subjects
with highest odds for a TKA were those in the lowest quartile of QoL
scores and with KL grade 3 or 4 radiographic severity.
Conclusions: These data suggest that knowledge of only a patient's age,
gender, KOOSQoL score and KL grade of severity of radiographic knee OA
can predict with high accuracy the odds of undergoing a TKA over the
ensuing5years. Theseﬁndingsextendourprior report (ShurupoffK, et al:
Osteoarthritis Cart 2011;19S1:S134 [abstract #284]) that KOOS QoL and
radiographic severity can be used tomodel the outcome of "Virtual TKA".
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THE CANONICAL WNT PATHWAY IS PREDOMINANTLY ACTIVATED IN
BONE IN OSTEOARTHRITIS
T. Funck-Brentano y,z, W. Bouaziz y, V. Geoffroy y, D. Hannouche k,x, C.
Marty y, E. Hay y, M.E. Cohen-Solal y,z. y INSERM U606 - Paris Diderot
Univ., Paris, France; zDept. of Rheumatology, Lariboisière Hosp., Paris,
France; xCNRS UMR 7052 - Paris Diderot Univ., Paris, France; kDept. of
Orthopedics, Lariboisière Hosp., Paris, France
Purpose: Wnt/b-catenin pathway is a main regulator of cartilage in
osteoarthritis (OA). However, previous studies targeting this pathway in
the cartilage have brought conﬂicting results, and the kinetic of activation
of this pathway in the joint is poorly known during the development of
OA. Moreover, the activation of the pathway in the tissues surrounding
the cartilage should also be characterized as they might impact cartilage
loss. Here, we aimed to investigate Wnt activation in cartilage, bone and
synovium and the expression of Wnt antagonists over time.
Methods: Topgal mice, that express b-galactosidasewhenWnt/b-catenin
is activated, were used to assess Wnt activation in the joints in vivo. To
promote a mechanical model of OA, mice underwent joint instability by
partial meniscectomy of the medial meniscus until baseline (n¼3), 4
(n¼14), 6 (n¼13), and9 (n¼9)weeks.Dissectedkneeswere scannedusing
an ex vivo microCT, then prepared for cryosectioning to quantify varia-
tions of Wnt activity in the 3 joint tissues by X-gal staining and the
expression ofWnt antagonists such asDickkopf-relatedprotein 1 (Dkk-1),
sclerostin and secreted frizzled-related protein 3 (sFRP-3) in the cartilage
overtime.Wnt activity was assessed by the number of X-gal positive cells
per tissue volume, and was expressed as a ratio of operated to sham-
operated knees for each animal and at each time point. Non parametric
testswere used: theWilcoxon's rank test for paired variables or theMann
Withney's test for independent variables. A p value< 0.05was considered
as statistically signiﬁcant.
Results: At baseline, X-gal staining was mainly located in osteocytes of
the subchondral bone and mostly absent in the articular cartilage. Wnt
activity decreased in osteocytes at week 4 (mean expression in operated
relative to sham-operated knees 0.50  0.08, p¼0.034), and then
increased at weeks 6 and 9 (1.63  0.43, p¼0.004 and 2.33  0.82,
p¼0.009, respectively). This activity paralleled the changes of sub-
chondral bone volume. Wnt activity was found in the endocortical
surface of growing osteophytes, and in the perichondrial groove of
Ranvier. They were lowWnt activation in articular chondrocytes during
the course of OA that were however more frequently observed in focal
cartilage lesions. At week 9, Wnt activation was predominant in sub-
chondral bone, osteophytes and synovium of operated knees.
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cartilage layers at baseline and in sham-operated knees, but greatly
decreased after partial meniscectomy from 4 weeks. Sclerostin and
sFRP-3 were expressed only in calciﬁed cartilage and increased with the
development of OA.
Conclusion: This in vivo study shows that in OA, the canonical Wnt
signaling pathway is mainly activated in subchondral bone, forming
osteophytes and synovium. Moreover, each Wnt antagonist has
a speciﬁc expression pattern in OA cartilage. Further studies are needed
to assess whether regulating Wnt activity in joint tissues can impact
cartilage loss in OA.7
IMPAIRED FRACTURE HEALING BY HIGHLY SELECTIVE COX-2
INHIBITION
M.P. Janssen y, M.M. Caron y, B. van Rietbergen z, T.J. Welting y, P.J.
Emans y. yMaastricht Univ. Med. Ctr., Maastricht, Netherlands;
z Technical Univ. Eindhoven, Eindhoven, Netherlands
Purpose: Non-steroidal anti-inﬂammatory drugs (NSAIDs) are widely
used for pain relief in osteoarthritis, after trauma and are used early
treatment of rheumatoid arthritis. More and more cyclooxygenase-2
selective NSAIDs are used because they induce fewer upper gastroin-
testinal complications. However, despite the positive applications of
these drugs there are also downsides to their use. In addition to the
previously described impairment of the osteogenic phase of endo-
chondral ossiﬁcation, we showed that NSAIDs have adverse effects on
the in vitro chondrogenic phase of endochondral ossiﬁcation as well.
We therefore hypothesized that highly selective COX-2 inhibition by
celecoxib impairs fracture healing not only in the osteogenic phase but
also in the chondrogenic phase in an in vivo rabbit model.
Methods: Fractures were simulated by the creation of a ‘critical size
defect’ in the left ulnas of 12 skeletally immature SPF New Zealand white
rabbits. Half of the rabbits received an oral dose of 10mg/kg celecoxib
each day from day 0. The control group was placebo treated. The
experiment was ended 25 days after initiation of the fractures.
After harvesting the ulnas were scanned using a micro-CT scanner
(micro-CT80, ScancoMedical, Bruettisellen Switzerland) and plain X-rays
were taken. Micro-CT images of the fracture region were used for Finite
Element Analysis (FEA) to determine the consolidation of the fractures.
Hereafter the ulnas were embedded in PMMA and 50mm thick sections
were cut for histological analysis. To determine the effect of celecoxib on
skeletal development, the growth plate region of ulnas from the
contralateral legwere decalciﬁed, embedded in parafﬁn and cut into 5mm
thick sections. The sections were haematoxylin stained and the total
growth plate thickness as well as thickness of the proliferative and
hypertrophic zones were determined. PGE2 concentrations in the plasma
(at the day of sacriﬁce) was determined using a speciﬁc ELISA.
Results: COX-2 inhibition by celecoxib was conﬁrmed by signiﬁcantly
decreased PGE2 levels in plasma of celecoxib-treated animals as
compared to control animals. The ulnar fractures in the rabbits which
were treated with celecoxib showed substantially less consolidation
than the fractures in the rabbits in the control group. On the plain X-rays
bigger gaps were observed in the fracture region than in the control
group. These ﬁndings were conﬁrmed by our micro-CT analysis.
Furthermore the FEA applied on the micro-CT datasets showed
a signiﬁcant decrease in compression stiffness of the fracture-region
and a decreasing trend in torsional stiffness, bending stiffness for
a moment around its x-axis and its y-axis. Histological sections of
the ulnar fractures showed a larger cartilaginous tissue fraction in the
fracture regions of the celecoxib-treated rabbits as compared to the
control group. Analysis of the ulnar growth plates showed a signiﬁcant
decrease in total growth plate thickness in the celecoxib- treated group.
When the proliferative and hypertrophic zones were scored separately,
no signiﬁcant difference was found between the proliferative zones,
however the hypertrophic zone was signiﬁcantly thinner in the cele-
coxib-treated group as compared to the control group.
Conclusions: We have shown that systemic COX-2 inhibition by cele-
coxib impairs fracture healing in an in vivo rabbit model. In additionwe
showed that chondrocyte hypertrophy in the ulnar growth plate is
inhibited. These ﬁndings suggest that the impaired fracture healing
might not be a speciﬁc consequence of impaired osteogenic phase, but
is at least in part a result of an effect of celecoxib on the chondrogenic
phase of endochondral ossiﬁcation.8
DIRECT ASSESSMENT OF ARTICULAR CARTILAGE AND UNDERLYING
SUBCHONDRAL BONE REVEALS A PROGRESSIVE GENE EXPRESSION
CHANGE IN HUMAN OSTEOARTHRITIC KNEES
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Lee x,{. yDuke Univ., Durham, NC, USA; z Taipei Med. Univ. Hosp., Taipei,
Taiwan; x Inst. of BioMed. Sci., Academia Sinica, Taipei, Taiwan; k Tri-
Service Gen. Hosp., Natl. Defense Med. Ctr., Taipei, Taiwan; {Ctr. for
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Purpose: To evaluate the interaction of articular cartilage (AC) and
subchondral bone (SB) through analysis of osteoarthritis (OA)-related
genes of site-matched tissue.
Methods: We developed a novel method for isolating site-matched
overlying AC and underlying SB from three and four regions of interest
respectively from the human knee tibial plateau (n¼50). For each site,
the severity of cartilage changes of OAwere assessed histologically, and
the severity of bone abnormalities were assessed by microcomputed
tomography. An RNA isolation procedure was optimized that yielded
high quality RNA from site-matched AC and SB tibial regions. Q-PCR
analysis was performed to evaluate gene expression of 61 OA-associ-
ated genes for correlation with cartilage integrity and bone structure
parameters.
Results: A total of 27 (44%) genes were coordinately up or down
regulated in both tissues. The expression levels of 19 genes were
statistically signiﬁcantly correlatedwith the severity of AC degeneration
and changes of SB structure; these included: ADAMTS1, ASPN, BMP6,
BMPER, CCL2, CCL8, COL5A1, COL6A3, COL7A1, COL16A1, FRZB, GDF10,
MMP3, OGN, OMD, POSTN, PTGES, TNFSF11 and WNT1.
Conclusions: These results provide a strategy for identifying targets
whose modiﬁcation may have the potential to ameliorate pathological
alterations and progression of disease in both AC and SB simultaneously.
In addition, this is theﬁrst study, to ourknowledge, to overcome themajor
difﬁculties related to isolation ofhighqualityRNA fromsite-matched joint
tissues. We expect this method to facilitate advances in our under-
standingof the coordinatedmolecular responses of thewhole joint organ.
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RNASE MRP IS A NOVEL REGULATOR OF ENDOCHONDRAL
OSSIFICATION
M.M. Caron y, M. Steinbusch y, K. Reicherter z, S. Mattijssen x, D.A.
Surtel y, L.W. van Rhijn y, G.J. Pruijn x, E. Lausch z, B. Zabel z, T.J.
Welting y. yDept. of Orthopaedic Surgery, Maastricht Univ. Med. Ctr.,
Maastricht, Netherlands; zCtr. for Paediatrics and Adolescent Med., Univ.
of Freiburg, Freiburg, Germany; xDept. of Biomolecular Chemistry,
Radboud Univ. Nijmegen, Nijmegen, Netherlands
Purpose: Mutations in the RMRP gene cause cartilage-hair hypoplasia
(CHH). CHH patients present with short stature (dwarﬁsm), sparse hair,
immunodeﬁciency and increased risk for malignancies. CHH is the ﬁrst
identiﬁed human disease caused by mutations in a small nucleolar
noncoding RNA molecule. RMRP RNA is the RNA subunit of the RNase
MRP complex, a macromolecular particle consisting of the RMRP RNA
and at least 7 different protein subunits (Rpp20, Rpp25, Rpp30, Rpp38,
Rpp40, Pop1 and Pop5). CHH-associated mutations in the RMRP gene
are thought to reduce its RNase enzymatic activity or to interfere with
its expression, however how this results in the development of CHH is
unknown. The most prominent phenotypic hallmark of CHH is
dwarﬁsm, suggesting that RNase MRP function is involved in develop-
ment of the growth plate. We therefore hypothesized that RNaseMRP is
involved in chondrogenic differentiation.
Methods: To investigate the expression of RNase MRP subunits during
chondrogenic differentiation in vivo, spatiotemporal expression of
